Ad is loading...
PGPRX
Price
$26.38
Change
-$0.24 (-0.90%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

PGPRX vs RLEFX

Header iconPGPRX vs RLEFX Comparison
Open Charts PGPRX vs RLEFXBanner chart's image
George Putnam Balanced R
Price$26.38
Change-$0.24 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
PGPRX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGPRX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGPRX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. PGPRX (2.11B). RLEFX pays higher dividends than PGPRX: RLEFX (2.42) vs PGPRX (0.89). PGPRX was incepted earlier than RLEFX: PGPRX (22 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. PGPRX (47.00). PGPRX has a lower initial minimum investment than RLEFX: PGPRX (0) vs RLEFX (250). PGPRX annual gain was more profitable for investors over the last year : 23.01 vs. RLEFX (21.09). RLEFX return over 5 years is better than : 35.95 vs. PGPRX (30.70).
PGPRXRLEFXPGPRX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD16.47914.211116%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B236B1%
Annual Yield % from dividends0.892.4237%
Returns for 1 year23.0121.09109%
Returns for 3 years5.9910.9555%
Returns for 5 years30.7035.9585%
Returns for 10 years71.62N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology